Liberty Health Sciences Inc (OTCMKTS: LHSIF) has been on the move in recent weeks running up the charts and more than doubling in the month of August alone. The stock has transformed in recent weeks to become a volume leader.
Liberty Health operates in the red hot cannabis market responsible for many of the hottest stocks and biggest winners in small caps. This is a booming sector as legal marijuana sales are expected to grow to more than $20 billion by 2022 according to Marijuana Business Daily. As October 17 looms closer Canadian MJ stocks have been heating up big time.
Liberty Health Sciences Inc (CSE: LHS) (OTCMKTS: LHSIF) bills itself as a cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do.
Through its wholly-owned subsidiary, DFMMJ Investments, llc dba Liberty Health Sciences Florida Ltd. Liberty is licensed to produce and sell medical cannabis products in the State of Florida. The Company is also focused on acquiring other cannabis businesses and expanding its operations throughout the United States, including a proposed investment in a Massachusetts-based business holding a medical cannabis license. Liberty was also awarded a dispensary license in Ohio in June 2018 and is developing operational plans with its joint venture partner.
Liberty’s business strategy is to acquire and operate vertically-integrated cannabis operations in states that are heavily populated with limited licenses in the United States. Liberty has the know-how and expertise to transform targeted investments into low-cost operations that produce high quality cannabis products while delivering value to its shareholders. Liberty has established strong relationships with producers of trans-dermal products and edibles in Florida and will transfer these arrangements to other states where possible.
In its inaugural fiscal year ended February 28, 2018, Liberty, through its wholly-owned subsidiary, Liberty Florida, purchased land, offices, processing facilities and approximately 12,000 square feet of greenhouses from Chestnut Hill Tree Farm. An expansion was completed in January 2018 which doubled the greenhouse capacity to approximately 1,600kgs of product per year. Given the rapidly growing demand for product in Florida, in February 2018, Liberty acquired a 387-acre site in Gainesville which was previously owned by Alico Citrus Nursery. Liberty is in the process of retrofitting the Alico property and in the meantime, continues to operate out of the expanded Chestnut facility. The Alico location has been re-branded as the Liberty 360 Innovation Campus and is expected to reach commercial production by early 2019. The combined production capacity of the Chestnut Facility and the Liberty 360 Campus will be approximately 14,600 kgs annually.
To Find out the inside Scoop on Liberty Health Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Last week Liberty Health said they experienced a 95% increase in sales revenue in the three-month period ended August 31, 2018 compared to the previous three-month period which ended May 31, 2018. Liberty’s recent quarterly revenue totaled $2.2 million compared to $1.1 million for the previous quarter, a 95% increase. The growth in revenue reflects the wider recognition of the Liberty brands in terms of quality and consistency as well as the patient-centric approach that the Company uses. The corresponding patient count increased to almost 10,000 patients at the end of August from 4,600 at the end of May, a 112% increase over this time period.
Further adding to the revenue growth is the expanding footprint in the state. The Company operates four dispensaries currently as well as six delivery hubs. Liberty has also signed seven new leases for dispensaries that are at various stages of permitting and construction. These new locations are expected to be opened by the end of February 2019, subject to the receipt of necessary approvals from the Florida Department of Health. The recently announced expansion of its one-day delivery services and the 24-hour or less turnaround throughout the entire state of Florida has also had a favorable impact on patient and revenue growth.
On September 10 Liberty Health announced it has become the first brand partner for the PAX Era, an easy-to-use, temperature controlled portable cannabis oil vaporizer, in the Florida market. The PAX Era vapor platform and compatible pod technology will be available in all of Liberty’s Cannabis Education Centers (CEC) locations and through delivery starting October 1, 2018. Liberty will offer several varieties of strains, designed for a wide array of uses and giving a broad range of choice to consumers.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $315 million market valuation Liberty Health has $38.8 million in the treasury, $131 million in assets and manageable debt. The Company boasts growing revenues recently reporting recent quarterly revenue totaled $2.2 million compared to $1.1 million for the previous quarter, a 95% increase. Liberty Health is a provider of trusted, high quality cannabis experiences and is quickly establishing itself as a major player in the Florida Cannabis market; the Company operates four dispensaries currently as well as six delivery hubs and has also signed seven new leases for dispensaries that are at various stages of permitting and construction and locations are expected to be opened by the end of February 2019. Liberty Health is also vamping up their production capacity and say they will be at 14,600 kgs annually by early next year. We will be updating on Liberty Health when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Liberty Health.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Liberty Health either long or short and we have not been compensated for this article.